Nabil Shabshab - Mar 1, 2022 Form 4 Insider Report for Inogen Inc (INGN)

Signature
/s/ Leslyn Cicekli, as Attorney-in-Fact
Stock symbol
INGN
Transactions as of
Mar 1, 2022
Transactions value $
-$542,058
Form type
4
Date filed
3/3/2022, 07:52 PM
Next filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INGN Common Stock Award $0 +9.41K $0.00 9.41K Mar 1, 2022 Direct F1
transaction INGN Common Stock Tax liability -$164K -4.67K -49.58% $35.21 4.74K Mar 1, 2022 Direct F2
transaction INGN Common Stock Options Exercise $0 +21.6K +456.18% $0.00 26.4K Mar 1, 2022 Direct
transaction INGN Common Stock Tax liability -$378K -10.7K -40.67% $35.21 15.7K Mar 1, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Options Exercise $0 -4.71K -25% $0.00 14.1K Mar 1, 2022 Common Stock 4.71K Direct F4, F5
transaction INGN Restricted Stock Unit Options Exercise $0 -16.9K -50% $0.00 16.9K Mar 1, 2022 Common Stock 16.9K Direct F4, F6
transaction INGN Restricted Stock Unit Award $0 +39.1K $0.00 39.1K Mar 1, 2022 Common Stock 39.1K Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on March 1, 2021.
F2 The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2021 performance-based restricted stock award granted on March 1, 2021 and vested on March 1, 2022.
F3 The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2022.
F4 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F5 Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.
F6 Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.
F7 Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.